Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors: an Eastern Cooperative Oncology Group, Southwest Oncology Group, and Cancer and Leukemia Group B Study.

作者: C R Nichols , P J Catalano , E D Crawford , N J Vogelzang , L H Einhorn

DOI: 10.1200/JCO.1998.16.4.1287

关键词:

摘要: PURPOSETo compare standard therapy with bleomycin, etoposide, and cisplatin (BEP) to experimental ifosfamide, (VIP) as primary treatment of men advanced, disseminated germ cell tumors.PATIENTS AND METHODSA total 304 advanced tumors were randomly allocated receive four courses BEP or VIP. Two hundred ninety-nine patients assessable for toxicity 286 response. Complete response rates, favorable (complete remission, surgical free disease, continuous partial remission 2+ years), time failure, overall survival assessed.RESULTSOverall complete rate (VIP, 37%; BEP, 31%), 63%; 60%), failure-free at 2 years 64%; 2-year 74%; 71%) not significantly different between the two treatments. Grade 3 worse toxicity, particularly hematologic genitourinary was sig...

参考文章(10)
Benton M Wheeler, PJ Loehrer, SD Williams, LH Einhorn, None, Ifosfamide in refractory male germ cell tumors. Journal of Clinical Oncology. ,vol. 4, pp. 28- 34 ,(1986) , 10.1200/JCO.1986.4.1.28
D F Bajorin, M F Sarosdy, D G Pfister, M Mazumdar, R J Motzer, H I Scher, N L Geller, W R Fair, H Herr, P Sogani, Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study Journal of Clinical Oncology. ,vol. 11, pp. 598- 606 ,(1993) , 10.1200/JCO.1993.11.4.598
L H Einhorn, Treatment of testicular cancer: a new and improved model. Journal of Clinical Oncology. ,vol. 8, pp. 1777- 1781 ,(1990) , 10.1200/JCO.1990.8.11.1777
Craig R Nichols, SD Williams, PJ Loehrer, FA Greco, ED Crawford, J Weetlaufer, ME Miller, A Bartolucci, L Schacter, LH Einhorn, None, Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: a Southeastern Cancer Study Group and Southwest Oncology Group protocol. Journal of Clinical Oncology. ,vol. 9, pp. 1163- 1172 ,(1991) , 10.1200/JCO.1991.9.7.1163
Lawrence H Einhorn, Stephen D Williams, Patrick J Loehrer, Robert Birch, Ray Drasga, George Omura, F Anthony Greco, None, Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol. Journal of Clinical Oncology. ,vol. 7, pp. 387- 391 ,(1989) , 10.1200/JCO.1989.7.3.387
Robert J. Motzer, Karen Cooper, Nancy L. Geller, Dean F. Bajorin, Ethan Dmitrovsky, Harry Herr, Michael Morse, William Fair, Pramod Sogani, Paul Russo, George J. Bosl, The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumors Cancer. ,vol. 66, pp. 2476- 2481 ,(1990) , 10.1002/1097-0142(19901215)66:12<2476::AID-CNCR2820661206>3.0.CO;2-D
Jean P. Droz, Marwane Ghosn, Gilles Piot, Christine Theodore, Jose L. Pico, Marcel Hayat, Andrew Kramar, Annie Rey, Pierre Wibault, Bernard H. Court, Jean L. Perrin, Jean P. Travagli, Dominique Bellet, J. M. Caillaud, Prognostic factors in advanced nonseminomatous testicular cancer. A multivariate logistic regression analysis. Cancer. ,vol. 62, pp. 564- 568 ,(1988) , 10.1002/1097-0142(19880801)62:3<564::AID-CNCR2820620321>3.0.CO;2-A
Robert Birch, Stephen Williams, Aet Cone, Lawrence Einhorn, Patricia Roark, Sandra Turner, FA Greco, None, Prognostic factors for favorable outcome in disseminated germ cell tumors Journal of Clinical Oncology. ,vol. 4, pp. 400- 407 ,(1986) , 10.1200/JCO.1986.4.3.400
Stephen D Williams, Robert Birch, Lawrence H Einhorn, Linda Irwin, F Anthony Greco, Patrick J Loehrer, None, Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or Etoposide New England Journal of Medicine. ,vol. 316, pp. 1435- 1440 ,(1987) , 10.1056/NEJM198706043162302
J.P. Droz, J.L. Pico, P. Biron, P. Kerbrat, H. Cure, J.F. Héron, B. Chevallier, P. Fargeot, (b) Kramar, J. Bouzy, C. Chevreau, Early intensified chemotherapy with autologous bone marrow transplantation in first line treatment of poor risk non-seminomatous germ cell tumours. Preliminary results of a French randomized trial. European Urology. ,vol. 23, pp. 213- 218 ,(1993) , 10.1159/000474596